cognitive cybersecurity intelligence

News and Analysis

Search

Wacker and Expression Manufacturing Partner to Advance Lentiviral-Based Gene and Cell Therapies

Wacker and Expression Manufacturing Partner to Advance Lentiviral-Based Gene and Cell Therapies

Wacker Biotech US and Expression Manufacturing have partnered to advance the development and manufacturing of lentiviral-based gene and cell therapies, providing an end-to-end solution for viral vector development and production. Wacker Biotech will offer its PLASMITEC® platform, microbial fermentation lines and pDNA capabilities. Expression will bring its LentET™ platform and viral vector manufacturing capabilities to the collaboration.

Source: www.genengnews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts